Rs6295 promoter variants of the serotonin type 1A receptor are differentially activated by c-Jun in vitro and correlate to transcript levels in human epileptic brain tissue

• Published in: Brain research 2013-03, Vol.1499, p.136-144
• Main Authors: Pernhorst, Katharina, van Loo, Karen M.J, von Lehe, Marec, Priebe, Lutz, Cichon, Sven, Herms, Stefan, Hoffmann, Per, Helmstaedter, Christoph, Sander, Thomas, Schoch, Susanne, Becker, Albert J
• Format: Article
• Language: English
• Subjects: Base Sequence; binding capacity; bioinformatics; Biological and medical sciences; brain; C-Jun; Computational Biology; DNA; epilepsy; Epilepsy - genetics; Epilepsy - metabolism; gene expression; genes; Genotype; genotyping; Headache. Facial pains. Syncopes. Epilepsia. Intracranial hypertension. Brain oedema. Cerebral palsy; Hippocampus - metabolism; homeostasis; homozygosity; Human brain tissue; Humans; JNK Mitogen-Activated Protein Kinases - metabolism; luciferase; Luciferase assay; Medical sciences; migraine; Molecular Sequence Data; Nervous system (semeiology, syndromes); Neurology; Oligonucleotide Array Sequence Analysis; patients; Polymorphism, Single Nucleotide; Promoter; promoter regions; Promoter Regions, Genetic - genetics; Real-Time Polymerase Chain Reaction; Receptor, Serotonin, 5-HT1A - genetics; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger - analysis; serotonin; surgery; transcription (genetics); transcription factors; Transcription, Genetic; Transfection
• ISSN: 0006-8993; 1872-6240
• DOI: 10.1016/j.brainres.2012.12.045

Abstract Many brain disorders, including epilepsy, migraine and depression, manifest with episodic symptoms that may last for various time intervals. Transient alterations of neuronal function such as related to serotonin homeostasis generally underlie this phenomenon. Several nucleotide polymorphisms (SNPs) in gene promoters associated with these diseases have been described. For obvious reasons, their regulatory roles on gene expression particularly in human brain tissue remain largely enigmatic. The rs6295 G-/C-allelic variant is located in the promoter region of the human HTR1a gene, encoding the G-protein-coupled receptor for 5-hydroxytryptamine (5HT1AR). In addition to reported transcriptional repressor binding, our bioinformatic analyses predicted a reduced binding affinity of the transcription factor (TF) c-Jun for the G-allele. In vitro luciferase transfection assays revealed c-Jun to (a) activate the rs6295 C- significantly stronger than the G-allelic variant and (b) antagonize efficiently the repressive effect of Hes5 on the promoter. The G-allele of rs6295 is known to be associated with aspects of major depression and migraine. In order to address a potential role of rs6295 variants in human brain tissue, we have isolated DNA and mRNA from fresh frozen hippocampal tissue of pharmacoresistant temporal lobe epilepsy (TLE) patients ( n =140) after epilepsy surgery for seizure control. We carried out SNP genotyping studies and mRNA analyses in order to determine HTR1a mRNA expression in human hippocampal samples stratified according to the rs6295 allelic variant. The mRNA expression of HTR1a was significantly more abundant in hippocampal mRNA of TLE patients homozygous for the rs6295 C-allele as compared to those with the GG-genotype. These data may point to a novel, i.e., rs6295 allelic variant and c-Jun dependent transcriptional 5HT1AR ‘receptoropathy’.